TOKYO, JP – PHC Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura; hereafter referred to as “PHC”), a subsidiary of PHC Holdings Corporation (Headquarters: Chiyoda-ku, Tokyo; President: Kyoko Deguchi), and Cyfuse… Read More
STEMCELL Technologies Canada Inc. to build two new cutting-edge biomanufacturing facilities to produce critical inputs used in the development and manufacture of vaccines, therapeutics and diagnostic technologies BURNABY, BC –… Read More
More consistent accumulation demonstrated in bloodstream over a one-week duration with once-daily DehydraTECH-tirzepatide oral capsules as compared to once-weekly injection of Zepbound® As previously announced, oral DehydraTECH-tirzepatide also reduced adverse… Read More
Getinge announces the launch of its latest innovation in ICU ventilation – Neural Pressure Support (NPS) – available for both invasive and non-invasive ventilation. Building on its most personalized ventilation… Read More
IXIFI® is a biosimilar to Remicade® (infliximab) IXIFI® is available in more than 20 countries and was approved by Health Canada in December 2021 Pfizer has been committed to patients on infliximab for… Read More
